Malaria: New antigens for a multicomponent blood-stage malaria vaccine

Science Translational Medicine

Volumn 6, Issue 247, 2014, Pages

  Osier, Faith H ^a   Mackinnon, Margaret J ^a   Crosnier, Cécile ^b   Fegan, Gregory ^a   Kamuyu, Gathoni ^a   Wanaguru, Madushi ^b   Ogada, Edna ^a   McDade, Brian ^b   Rayner, Julian C ^b   Wright, Gavin J ^b   Marsh, Kevin ^a  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMA1 ANTIGEN; MALARIA VACCINE; MSP11 ANTIGEN; MSP2 ANTIGEN; MSP3 ANTIGEN; MSRP1 ANTIGEN; P41 ANTIGEN; PARASITE ANTIGEN; PF113 ANTIGEN; PF3D7 0606800 ANTIGEN; PF3D7 1136200 ANTIGEN; RHOPH3 ANTIGEN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MEROZOITE SURFACE PROTEIN 2, PLASMODIUM; MSP3 PROTEIN, PLASMODIUM FALCIPARUM (181-276); PEPTIDE FRAGMENT; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY; RHOPTRY ASSOCIATED PROTEIN, PLASMODIUM;

ANTIBODY RESPONSE; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG EFFICACY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; KENYA; MALARIA; MEROZOITE; OBSERVATIONAL STUDY; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; VACCINATION; AGE; BLOOD; COMPARATIVE STUDY; IMMUNOLOGY; INFANT; MALARIA, FALCIPARUM; NEWBORN; PARASITOLOGY; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; TIME; TRANSMISSION;

AGE FACTORS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; KENYA; MALARIA VACCINES; MALARIA, FALCIPARUM; MEROZOITES; PEPTIDE FRAGMENTS; PLASMODIUM FALCIPARUM; PROSPECTIVE STUDIES; PROTOZOAN PROTEINS; SEROEPIDEMIOLOGIC STUDIES; TIME FACTORS;

EID: 84907968685     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3008705     Document Type: Article

References (58)

1. J. Langhorne, F. M. Ndungu, A. M. Sponaas, K. Marsh, Immunity to malaria: More questions than answers. Nat. Immunol. 9, 725-732 (2008). (Pubitemid 351859155)
2. S. Cohen, I. McGregor, S. Carrington, Gamma-globulin and acquired immunity to human malaria. Nature 192, 733-737 (1961).
3. B. S. Crabb, J. G. Beeson, R. Amino, R. Ménard, A. Waters, E. A. Winzeler, M. Wahlgren, D. A. Fidock, S. Nwaka, Perspectives: The missing pieces. Nature 484, S22-S23 (2012).
4. F. J. Fowkes, J. S. Richards, J. A. Simpson, J. G. Beeson, The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and metaanalysis. PLOS Med. 7, e1000218 (2010).
5. P. D. Crompton, M. A. Kayala, B. Traore, K. Kayentao, A. Ongoiba, G. E. Weiss, D. M. Molina, C. R. Burk, M. Waisberg, A. Jasinskas, X. Tan, S. Doumbo, D. Doumtabe, Y. Kone, D. L. Narum, X. Liang, O. K. Doumbo, L. H. Miller, D. L. Doolan, P. Baldi, P. L. Felgner, S. K. Pierce, A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc. Natl. Acad. Sci. U. S. A. 107, 6958-6963 (2010).
6. D. L. Doolan, Y. Mu, B. Unal, S. Sundaresh, S. Hirst, C. Valdez, A. Randall, D. Molina, X. Liang, D. A. Freilich, J. A. Oloo, P. L. Blair, J. C. Aguiar, P. Baldi, D. H. Davies, P. L. Felgner, Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics 8, 4680-4694 (2008).
7. A. Trieu, M. A. Kayala, C. Burk, D. M. Molina, D. A. Freilich, T. L. Richie, P. Baldi, P. L. Felgner, D. L. Doolan, Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens. Mol. Cell. Proteomics 10, M111.007948 (2011).
8. T. Tsuboi, S. Takeo, H. Iriko, L. Jin, M. Tsuchimochi, S. Matsuda, E. T. Han, H. Otsuki, O. Kaneko, J. Sattabongkot, R. Udomsangpetch, T. Sawasaki, M. Torii, Y. Endo, Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates. Infect. Immun. 76, 1702-1708 (2008). (Pubitemid 351562015)
9. L. M. Birkholtz, G. Blatch, T. L. Coetzer, H. C. Hoppe, E. Human, E. J. Morris, Z. Ngcete, L. Oldfield, R. Roth, A. Shonhai, L. Stephens, A. I. Louw, Heterologous expression of plasmodial proteins for structural studies and functional annotation. Malar. J. 7, 197 (2008).
10. N. S. Outchkourov, W. Roeffen, A. Kaan, J. Jansen, A. Luty, D. Schuiffel, G. J. van Gemert, M. van de Vegte-Bolmer, R. W. Sauerwein, H. G. Stunnenberg, Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice. Proc. Natl. Acad. Sci. U. S. A. 105, 4301-4305 (2008). (Pubitemid 351754375)
11. R. F. Anders, P. E. Crewther, S. Edwards, M. Margetts, M. L. Matthew, B. Pollock, D. Pye, Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. Vaccine 16, 240-247 (1998). (Pubitemid 27521005)
12. A. F. Cowman, D. Berry, J. Baum, The cellular and molecular basis for malaria parasite invasion of the human red blood cell. J. Cell Biol. 198, 961-971 (2012).
13. S. Dutta, P. V. Lalitha, L. A. Ware, A. Barbosa, J. K. Moch, M. A. Vassell, B. B. Fileta, S. Kitov, N. Kolodny, D. G. Heppner, J. D. Haynes, D. E. Lanar, Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli. Infect. Immun. 70, 3101-3110 (2002). (Pubitemid 34564173)
14. S. D. Polley, K. K. Tetteh, J. M. Lloyd, O. J. Akpogheneta, B. M. Greenwood, K. A. Bojang, D. J. Conway, Plasmodium falciparum merozoite surface protein 3 is a target of allelespecific immunity and alleles are maintained by natural selection. J. Infect. Dis. 195, 279-287 (2007). (Pubitemid 46080060)
15. R. R. Taylor, D. B. Smith, V. J. Robinson, J. S. McBride, E. M. Riley, Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass. Infect. Immun. 63, 4382-4388 (1995).
16. F. H. Osier, G. Fegan, S. D. Polley, L. Murungi, F. Verra, K. K. Tetteh, B. Lowe, T. Mwangi, P. C. Bull, A. W. Thomas, D. R. Cavanagh, J. S. McBride, D. E. Lanar, M. J. Mackinnon, D. J. Conway, K. Marsh, Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect. Immun. 76, 2240-2248 (2008). (Pubitemid 351656161)
17. F. H. Osier, S. D. Polley, T. Mwangi, B. Lowe, D. J. Conway, K. Marsh, Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3. Parasite Immunol. 29, 387-394 (2007). (Pubitemid 47083924)
18. F. H. Osier, G. D. Weedall, F. Verra, L. Murungi, K. K. Tetteh, P. Bull, B. W. Faber, E. Remarque, A. Thomas, K. Marsh, D. J. Conway, Allelic diversity and naturally acquired allele-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 in Kenya. Infect. Immun. 78, 4625-4633 (2010).
19. F. H. Osier, L. M. Murungi, G. Fegan, J. Tuju, K. K. Tetteh, P. C. Bull, D. J. Conway, K. Marsh, Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria. Parasite Immunol. 32, 193-201 (2010).
20. S. D. Polley, D. J. Conway, D. R. Cavanagh, J. S. McBride, B. S. Lowe, T. N. Williams, T. W. Mwangi, K. Marsh, High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Vaccine 24, 4233-4246 (2006).
21. S. D. Polley, T. Mwangi, C. H. Kocken, A. W. Thomas, S. Dutta, D. E. Lanar, E. Remarque, A. Ross, T. N. Williams, G. Mwambingu, B. Lowe, D. J. Conway, K. Marsh, Human antibodies to recombinant protein constructs of Plasmodium falciparum apical membrane antigen 1 (AMA1) and their associations with protection from malaria. Vaccine 23, 718-728 (2004). (Pubitemid 39473204)
22. K. K. Tetteh, F. H. Osier, A. Salanti, G. Kamuyu, L. Drought, M. Failly, C. Martin, K. Marsh, D. J. Conway, Analysis of antibodies to newly described Plasmodium falciparum merozoite antigens supports MSPDBL2 as a predicted target of naturally acquired immunity. Infect. Immun. 81, 3835-3842 (2013).
23. C. C. John, A. M. Moormann, D. C. Pregibon, P. O. Sumba, M. M. McHugh, D. L. Narum, D. E. Lanar, M. D. Schluchter, J. W. Kazura, Correlation of high levels of antibodies to multiple preerythrocytic Plasmodium falciparum antigens and protection from infection. Am. J. Trop. Med. Hyg. 73, 222-228 (2005). (Pubitemid 41278777)
24. J. S. Richards, D. I. Stanisic, F. J. Fowkes, L. Tavul, E. Dabod, J. K. Thompson, S. Kumar, C. E. Chitnis, D. L. Narum, P. Michon, P. M. Siba, A. F. Cowman, I. Mueller, J. G. Beeson, Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia. Clin. Infect. Dis. 51, e50-e60 (2010).
25. M. J. Gardner, N. Hall, E. Fung, O. White, M. Berriman, R. W. Hyman, J. M. Carlton, A. Pain, K. E. Nelson, S. Bowman, I. T. Paulsen, K. James, J. A. Eisen, K. Rutherford, S. L. Salzberg, A. Craig, S. Kyes, M. S. Chan, V. Nene, S. J. Shallom, B. Suh, J. Peterson, S. Angiuoli, M. Pertea, J. Allen, J. Selengut, D. Haft, M. W. Mather, A. B. Vaidya, D. M. Martin, A. H. Fairlamb, M. J. Fraunholz, D. S. Roos, S. A. Ralph, G. I. McFadden, L. M. Cummings, G. M. Subramanian, C. Mungall, J. C. Venter, D. J. Carucci, S. L. Hoffman, C. Newbold, R. W. Davis, C. M. Fraser, B. Barrell, Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419, 498-511 (2002).
26. J. C. Gray, P. H. Corran, E. Mangia, M. W. Gaunt, Q. Li, K. K. Tetteh, S. D. Polley, D. J. Conway, A. A. Holder, T. Bacarese-Hamilton, E. M. Riley, A. Crisanti, Profiling the antibody immune response against blood stage malaria vaccine candidates. Clin. Chem. 53, 1244-1253 (2007). (Pubitemid 47020980)
27. S. J. Bartholdson, L. Y. Bustamante, C. Crosnier, S. Johnson, S. Lea, J. C. Rayner, G. J. Wright, Semaphorin-7A is an erythrocyte receptor for P. falciparum merozoite-specific TRAP homolog, MTRAP. PLOS Pathog. 8, e1003031 (2012).
28. C. Crosnier, L. Y. Bustamante, S. J. Bartholdson, A. K. Bei, M. Theron, M. Uchikawa, S. Mboup, O. Ndir, D. P. Kwiatkowski, M. T. Duraisingh, J. C. Rayner, G. J. Wright, Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature 480, 534-537 (2011).
29. L. Y. Bustamante, S. J. Bartholdson, C. Crosnier, M. G. Campos, M. Wanaguru, C. Nguon, D. P. Kwiatkowski, G. J. Wright, J. C. Rayner, A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants. Vaccine 31, 373-379 (2013).
30. A. D. Douglas, A. R. Williams, J. J. Illingworth, G. Kamuyu, S. Biswas, A. L. Goodman, D. H. Wyllie, C. Crosnier, K. Miura, G. J. Wright, C. A. Long, F. H. Osier, K. Marsh, A. V. Turner, A. V. Hill, S. J. Draper, The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat. Commun. 2, 601 (2011).
31. K. Miura, H. Zhou, A. Diouf, G. Tullo, S. E. Moretz, J. A. Aebig, M. P. Fay, L. H. Miller, O. K. Doumbo, I. Sagara, A. Dicko, C. A. Long, R. D. Ellis, Immunological responses against Plasmodium falciparum apical membrane antigen 1 vaccines vary depending on the population immunized. Vaccine 29, 2255-2261 (2011).
32. J. S. Richards, T. U. Arumugam, L. Reiling, J. Healer, A. N. Hodder, F. J. Fowkes, N. Cross, C. Langer, S. Takeo, A. D. Uboldi, J. K. Thompson, P. R. Gilson, R. L. Coppel, P. M. Siba, C. L. King, M. Torii, C. E. Chitnis, D. L. Narum, I. Mueller, B. S. Crabb, A. F. Cowman, T. Tsuboi, J. G. Beeson, Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development. J. Immunol. 191, 795-809 (2013).
33. L. M. Murungi, G. Kamuyu, B. Lowe, P. Bejon, M. Theisen, S. M. Kinyanjui, K. Marsh, F. H. Osier, A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria. Vaccine 31, 3936-3942 (2013).
34. J. Rono, F. H. Osier, D. Olsson, S. Montgomery, L. Mhoja, I. Rooth, K. Marsh, A. Färnert, Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria. Clin. Infect. Dis. 57, 1409-1416 (2013).
35. V. Meraldi, I. Nebié, A. B. Tiono, D. Diallo, E. Sanogo, M. Theisen, P. Druilhe, G. Corradin, R. Moret, B. S. Sirima, Natural antibody response to Plasmodium falciparum Exp-1, MSP-3 and GLURP long synthetic peptides and association with protection. Parasite Immunol. 26, 265-272 (2004). (Pubitemid 39576327)
36. L. Reiling, J. S. Richards, F. J. Fowkes, A. E. Barry, T. Triglia, W. Chokejindachai, P. Michon, L. Tavul, P. M. Siba, A. F. Cowman, I. Mueller, J. G. Beeson, Evidence that the erythrocyte invasion ligand PfRh2 is a target of protective immunity against Plasmodium falciparum malaria. J. Immunol. 185, 6157-6167 (2010).
37. D. I. Stanisic, J. S. Richards, F. J. McCallum, P. Michon, C. L. King, S. Schoepflin, P. R. Gilson, V. J. Murphy, R. F. Anders, I. Mueller, J. G. Beeson, Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Infect. Immun. 77, 1165-1174 (2009).
38. S. A. Plotkin, Vaccines: Correlates of vaccine-induced immunity. Clin. Infect. Dis. 47, 401-409 (2008).
39. K. Marsh, S. Kinyanjui, Immune effector mechanisms in malaria. Parasite Immunol. 28, 51-60 (2006).
40. B. Genton, I. Betuela, I. Felger, F. Al-Yaman, R. F. Anders, A. Saul, L. Rare, M. Baisor, K. Lorry, G. V. Brown, D. Pye, D. O. Irving, T. A. Smith, H. P. Beck, M. P. Alpers, A recombinant bloodstage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J. Infect. Dis. 185, 820-827 (2002). (Pubitemid 34226210)
41. M. A. Thera, O. K. Doumbo, D. Coulibaly, M. B. Laurens, A. Ouattara, A. K. Kone, A. B. Guindo, K. Traore, I. Traore, B. Kouriba, D. A. Diallo, I. Diarra, M. Daou, A. Dolo, Y. Tolo, M. S. Sissoko, A. Niangaly, M. Sissoko, S. Takala-Harrison, K. E. Lyke, Y. Wu, W. C. Blackwelder, O. Godeaux, J. Vekemans, M. C. Dubois, W. R. Ballou, J. Cohen, D. Thompson, T. Dube, L. Soisson, C. L. Diggs, B. House, D. E. Lanar, S. Dutta, D. G. Heppner Jr., C. V. Plowe, A field trial to assess a blood-stage malaria vaccine. N. Engl. J. Med. 365, 1004-1013 (2011).
42. O. J. Akpogheneta, N. O. Duah, K. K. Tetteh, S. Dunyo, D. E. Lanar, M. Pinder, D. J. Conway, Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. Infect. Immun. 76, 1748-1755 (2008). (Pubitemid 351562020)
43. S. M. Kinyanjui, D. J. Conway, D. E. Lanar, K. Marsh, IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar. J. 6, 82 (2007).
44. M. B. McCarra, G. Ayodo, P. O. Sumba, J. W. Kazura, A. M. Moormann, D. L. Narum, C. C. John, Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria. Pediatr. Infect. Dis. J. 30, 1037-1042 (2011).
45. L. Reiling, J. S. Richards, F. J. Fowkes, D. W. Wilson, W. Chokejindachai, A. E. Barry, W. H. Tham, J. Stubbs, C. Langer, J. Donelson, P. Michon, L. Tavul, B. S. Crabb, P. M. Siba, A. F. Cowman, I. Mueller, J. G. Beeson, The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria. PLOS One 7, e45253 (2012).
46. A. G. Maier, M. T. Duraisingh, J. C. Reeder, S. S. Patel, J. W. Kazura, P. A. Zimmerman, A. F. Cowman, Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations. Nat. Med. 9, 87-92 (2003). (Pubitemid 36098265)
47. B. K. Sim, C. E. Chitnis, K. Wasniowska, T. J. Hadley, L. H. Miller, Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science 264, 1941-1944 (1994). (Pubitemid 24245642)
48. J. A. Chan, K. B. Howell, L. Reiling, R. Ataide, C. L. Mackintosh, F. J. Fowkes, M. Petter, J. M. Chesson, C. Langer, G. M. Warimwe, M. F. Duffy, S. J. Rogerson, P. C. Bull, A. F. Cowman, K. Marsh, J. G. Beeson, Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity. J. Clin. Invest. 122, 3227-3238 (2012).
49. J. G. Beeson, J. A. Chan, F. J. Fowkes, PfEMP1 as a target of human immunity and a vaccine candidate against malaria. Expert Rev. Vaccines 12, 105-108 (2013).
50. A. K. Pandey, K. S. Reddy, T. Sahar, S. Gupta, H. Singh, E. J. Reddy, M. Asad, F. A. Siddiqui, P. Gupta, B. Singh, K. R. More, A. Mohmmed, C. E. Chitnis, V. S. Chauhan, D. Gaur, Identification of a potent combination of key Plasmodium falciparum merozoite antigens that elicit strain-transcending parasite-neutralizing antibodies. Infect. Immun. 81, 441-451 (2013).
51. A. R. Williams, A. D. Douglas, K. Miura, J. J. Illingworth, P. Choudhary, L. M. Murungi, J. M. Furze, A. Diouf, O. Miotto, C. Crosnier, G. J. Wright, D. P. Kwiatkowski, R. M. Fairhurst, C. A. Long, S. J. Draper, Enhancing blockade of Plasmodium falciparum erythrocyte invasion: Assessing combinations of antibodies against PfRH5 and other merozoite antigens. PLOS Pathog. 8, e1002991 (2012).
52. C. Joos, L. Marrama, H. E. Polson, S. Corre, A. M. Diatta, B. Diouf, J. F. Trape, A. Tall, S. Longacre, R. Perraut, Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies. PLOS One 5, e9871 (2010).
53. S. Singh, S. Soe, S. Weisman, J. W. Barnwell, J. L. Pérignon, P. Druilhe, A conserved multigene family induces cross-reactive antibodies effective in defense against Plasmodium falciparum. PLOS One 4, e5410 (2009).
54. T. W. Mwangi, A. Ross, R. W. Snow, K. Marsh, Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya. J. Infect. Dis. 191, 1932-1939 (2005). (Pubitemid 40705402)
55. C. M. Mbogo, J. M. Mwangangi, J. Nzovu, W. Gu, G. Yan, J. T. Gunter, C. Swalm, J. Keating, J. L. Regens, J. I. Shililu, J. I. Githure, J. C. Beier, Spatial and temporal heterogeneity of Anopheles mosquitoes and Plasmodium falciparum transmission along the Kenyan coast. Am. J. Trop. Med. Hyg. 68, 734-742 (2003). (Pubitemid 38235106)
56. C. Crosnier, M. Wanaguru, B. McDade, F. H. Osier, K. Marsh, J. C. Rayner, G. J. Wright, A library of functional recombinant cell-surface and secreted P. falciparum merozoite proteins. Mol. Cell. Proteomics 12, 3976-3986 (2013).
57. R Development Core Team, R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna, Austria, 2011).
58. G. Zou, A modified Poisson regression approach to prospective studies with binary data. Am. J. Epidemiol. 159, 702-706 (2004). (Pubitemid 38405384)